Merit Medical Systems, Inc. (MMSI)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
$90.63+7.69%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · MMSI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -5.7% |
| Our one-year growth estimate | diamond | 6.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 12.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 10 industry peers · Company calendar date is not available
MMSI — COO transition
Dated 2026-08-20
Chief Operating Officer — Neil W. Peterson: The Chief Operating Officer position was eliminated and the incumbent resigned for good reason, representing a loss of a senior executive despite the simultaneous external hire.
Why it matters: Management says the plan is in its final stages. Its goals can show how Merit plans to keep growth and profit rising.
Supportive ifMerit shares a plan with clear steps to support lasting growth and higher profit.
Worry ifMerit delays the plan, or shares targets that call for lower growth or profit.
Why it matters: Cash flow from operations was $175.2 million year to date. More cash can help Merit fund growth and manage debt.
Watch forFull-year 2026 cash flow from operations exceeds the 2025 full-year level.
Also watch forFull-year 2026 cash flow from operations falls below the 2025 full-year level.
Why it matters: Merit raised its profit range after nine months of growth. Falling short would weaken that progress.
Worry ifFull-year 2026 non-GAAP EPS is below $4.33, the low end of the raised range.
Less concerning ifFull-year 2026 non-GAAP EPS is at least $4.33.
Why it matters: Merit raised its 2026 revenue range after strong nine-month results. A miss would break that growth trend.
Worry ifFull-year 2026 revenue is below $1.635 billion, the low end of the raised range.
Less concerning ifFull-year 2026 revenue is at least $1.635 billion.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$96 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $278 loss on $10,000 · 2.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,528 loss on $10,000 · 35.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.